Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Prognostic value of IL-34 in colorectal cancer patients.

Kobayashi T, Baghdadi M, Han N, Murata T, Hama N, Otsuka R, Wada H, Shiozawa M, Yokose T, Miyagi Y, Takano A, Daigo Y, Seino KI.

Immunol Med. 2019 Nov 23:1-7. doi: 10.1080/25785826.2019.1691429. [Epub ahead of print]

PMID:
31762401
2.

Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.

Suzuki M, Muroi A, Nojima M, Numata A, Takasaki H, Sakai R, Yokose T, Miyagi Y, Koshikawa N.

Proteomics Clin Appl. 2019 Nov 13:e1900091. doi: 10.1002/prca.201900091. [Epub ahead of print]

PMID:
31721454
3.

Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.

Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Oridate N.

Head Neck. 2019 Oct 24. doi: 10.1002/hed.25994. [Epub ahead of print]

PMID:
31647162
4.

Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.

Samejima J, Yokose T, Ito H, Nakayama H, Nagashima T, Suzuki M, Hamanaka R, Yamada K, Masuda M.

Lung Cancer. 2019 Nov;137:144-148. doi: 10.1016/j.lungcan.2019.09.022. Epub 2019 Sep 29.

PMID:
31593845
5.

Effect of progressive sarcopenia during postoperative 6 months on long-term prognosis of completely resected lung cancer.

Nagata M, Ito H, Yokose T, Tokushige A, Ueda S, Nakayama H.

J Thorac Dis. 2019 Aug;11(8):3411-3420. doi: 10.21037/jtd.2019.08.16.

6.

Two cases of lung neuroendocrine carcinoma with carcinoid morphology.

Inafuku K, Yokose T, Ito H, Eriguchi D, Samejima J, Nagashima T, Nakayama H, Suzuki M, Yamada K, Masuda M.

Diagn Pathol. 2019 Sep 12;14(1):104. doi: 10.1186/s13000-019-0886-1.

7.

Should Pathologically Noninvasive Lung Adenocarcinoma Larger Than 3 cm Be Classified as T1a?

Inafuku K, Yokose T, Ito H, Narimatsu H, Samejima J, Nagashima T, Nakayama H, Suzuki M, Yamada K, Masuda M.

Ann Thorac Surg. 2019 Dec;108(6):1678-1684. doi: 10.1016/j.athoracsur.2019.06.055. Epub 2019 Aug 7.

PMID:
31400323
8.

Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report.

Endo Y, Oshima G, Hibi T, Shinoda M, Sakurai M, Koda Y, Izawa Y, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Fukushima A, Yokose T, Mori T, Kuroda T, Kitagawa Y.

Transplantation. 2019 Nov;103(11):e375-e377. doi: 10.1097/TP.0000000000002904. No abstract available.

PMID:
31397803
9.

Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis.

Isaka T, Ito H, Nakayama H, Yokose T, Katayama K, Yamada K, Masuda M.

Mol Diagn Ther. 2019 Oct;23(5):657-665. doi: 10.1007/s40291-019-00419-9.

PMID:
31347029
10.

Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity.

Matsumura Y, Ito Y, Mezawa Y, Sulidan K, Daigo Y, Hiraga T, Mogushi K, Wali N, Suzuki H, Itoh T, Miyagi Y, Yokose T, Shimizu S, Takano A, Terao Y, Saeki H, Ozawa M, Abe M, Takeda S, Okumura K, Habu S, Hino O, Takeda K, Hamada M, Orimo A.

Life Sci Alliance. 2019 Jul 22;2(4). pii: e201900425. doi: 10.26508/lsa.201900425. Print 2019 Aug.

11.

Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trial.

Takeuchi M, Obara H, Kawakubo H, Shinoda M, Okabayashi K, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitago M, Yagi H, Abe Y, Oshima G, Hori S, Tsuruta M, Ishida T, Yokose T, Hirukawa K, Isobe Y, Sekimoto Y, Harada H, Maeda Y, Shito M, Kondo T, Sato Y, Kitagawa Y.

BMJ Open. 2019 May 28;9(5):e028269. doi: 10.1136/bmjopen-2018-028269.

12.

CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.

Mezawa Y, Daigo Y, Takano A, Miyagi Y, Yokose T, Yamashita T, Morimoto C, Hino O, Orimo A.

Cancer Med. 2019 Jul;8(8):3936-3948. doi: 10.1002/cam4.2249. Epub 2019 May 29.

13.

Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature.

Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y.

World J Gastroenterol. 2019 Apr 21;25(15):1899-1906. doi: 10.3748/wjg.v25.i15.1899. Review.

14.

CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma.

Mochizuki M, Nakamura M, Sibuya R, Okazaki T, Abe J, Nakagawa T, Takahashi S, Yamazaki T, Imai T, Takano A, Ito H, Yokose T, Miyagi Y, Daigo Y, Sato I, Satoh K, Sugamura K, Yamaguchi K, Tamai K.

Lab Invest. 2019 Sep;99(9):1349-1362. doi: 10.1038/s41374-019-0246-5. Epub 2019 Apr 24.

PMID:
31019292
15.

Which Window Setting Is Best for Estimating Pathologic Invasive Size and Invasiveness?

Samejima J, Ito H, Nakayama H, Nagashima T, Osawa J, Inafuku K, Suzuki M, Yokose T, Yamada K, Masuda M.

Ann Thorac Surg. 2019 Aug;108(2):384-391. doi: 10.1016/j.athoracsur.2019.03.041. Epub 2019 Apr 12.

PMID:
30986418
16.

[A Case of Mediastinal Lymph Node Recurrence after Endoscopic Submucosal Dissection of Esophageal Cancer].

Nagasawa S, Ogata T, Hara K, Osakabe H, Shimoda Y, Nakazono M, Kumazu Y, Hayashi T, Yamada T, Okubo Y, Yokose T, Rino Y, Masuda M, Oshima T, Yoshikawa T.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2297-2299. Japanese.

PMID:
30692443
17.

[A Case of Liver Metastasis 14 Years after Total Gastrectomy for Advanced Gastric Cancer].

Hara K, Yamada T, Osakabe H, Shimoda Y, Nakazono M, Nagasawa S, Kumazu Y, Hayashi T, Yoshioka E, Yokose T, Rino Y, Masuda M, Ogata T, Oshima T, Yoshikawa T.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2018-2020. Japanese.

PMID:
30692430
18.

Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin.

Hashizume A, Umemoto S, Yokose T, Nakamura Y, Yoshihara M, Shoji K, Wada S, Miyagi Y, Kishida T, Sasada T.

Oncotarget. 2018 Sep 25;9(75):34066-34078. doi: 10.18632/oncotarget.26122. eCollection 2018 Sep 25.

19.

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.

Isaka T, Nakayama H, Ito H, Yokose T, Yamada K, Masuda M.

BMC Cancer. 2018 Oct 5;18(1):959. doi: 10.1186/s12885-018-4849-9.

20.

Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review.

Okubo Y, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Kameda Y, Yokose T.

Front Oncol. 2018 Jul 27;8:291. doi: 10.3389/fonc.2018.00291. eCollection 2018.

21.

Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer.

Yamazaki H, Yokose T, Hayashi H, Iwasaki H, Osanai S, Suganuma N, Nakayama H, Masudo K, Rino Y, Masuda M.

Cancer Chemother Pharmacol. 2018 Oct;82(4):649-654. doi: 10.1007/s00280-018-3657-x. Epub 2018 Jul 26.

PMID:
30051190
22.

Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma.

Suzuki M, Nakatani Y, Ito H, Narimatsu H, Yamada K, Yoshioka E, Washimi K, Okubo Y, Kawachi K, Miyagi Y, Yokose T.

Mod Pathol. 2018 Sep;31(9):1404-1417. doi: 10.1038/s41379-018-0057-z. Epub 2018 May 21.

23.

Long-term survival with extended lateral lymphadenectomy for lateral lymph node recurrence after laparoscopic abdominoperineal resection for rectal adenosquamous carcinoma: a case report.

Yokose T, Yamamoto S, Nagase T, Kanai T, Takano K, Fujii T, Tsutsui M, Nakagawa M, Ochiai H, Kameyama K.

Surg Case Rep. 2018 Apr 10;4(1):32. doi: 10.1186/s40792-018-0440-5.

24.

High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.

Baghdadi M, Endo H, Takano A, Ishikawa K, Kameda Y, Wada H, Miyagi Y, Yokose T, Ito H, Nakayama H, Daigo Y, Suzuki N, Seino KI.

Sci Rep. 2018 Jan 11;8(1):418. doi: 10.1038/s41598-017-18796-8.

25.

Detection of Mycobacterium tuberculosis-derived DNA in circulating cell-free DNA from a patient with disseminated infection using digital PCR.

Yamamoto M, Ushio R, Watanabe H, Tachibana T, Tanaka M, Yokose T, Tsukiji J, Nakajima H, Kaneko T.

Int J Infect Dis. 2018 Jan;66:80-82. doi: 10.1016/j.ijid.2017.11.018. Epub 2017 Nov 14.

26.

Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: a retrospective study.

Okubo Y, Kasajima R, Suzuki M, Miyagi Y, Motohashi O, Shiozawa M, Yoshioka E, Washimi K, Kawachi K, Kameda Y, Yokose T.

BMC Cancer. 2017 Nov 16;17(1):769. doi: 10.1186/s12885-017-3769-4.

27.

Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Miyaoka M, Kikuti YY, Carreras J, Ikoma H, Hiraiwa S, Ichiki A, Kojima M, Ando K, Yokose T, Sakai R, Hoshikawa M, Tomita N, Miura I, Takata K, Yoshino T, Takizawa J, Bea S, Campo E, Nakamura N.

Mod Pathol. 2018 Feb;31(2):313-326. doi: 10.1038/modpathol.2017.134. Epub 2017 Oct 6.

28.

Clear cell sarcoma-like tumor of the gastrointestinal tract: A clinicopathological review.

Washimi K, Takagi M, Hisaoka M, Kawachi K, Takeyama M, Hiruma T, Narimatsu H, Yokose T.

Pathol Int. 2017 Oct;67(10):534-536. doi: 10.1111/pin.12573. Epub 2017 Sep 9. Review. No abstract available.

PMID:
28887884
29.

Detection of tumor spread through airspaces by airway secretion cytology from resected lung cancer specimens.

Isaka T, Yokose T, Miyagi Y, Washimi K, Nishii T, Ito H, Nakayama H, Yamada K, Masuda M.

Pathol Int. 2017 Oct;67(10):487-494. doi: 10.1111/pin.12570. Epub 2017 Aug 31.

PMID:
28857359
30.

Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum: a case report.

Hayakawa T, Nonaka T, Mizoguchi N, Hagiwara Y, Shibata S, Sakai R, Nakayama N, Yokose T, Nakayama Y.

Clin J Gastroenterol. 2017 Oct;10(5):431-436. doi: 10.1007/s12328-017-0769-5. Epub 2017 Aug 16.

PMID:
28815477
31.

Chronic lymphocytic leukemia/small lymphocytic lymphoma with t (2;18) (p12;q21) accompanied by a cutaneous nodule with histological features of diffuse large B-cell lymphoma.

Koyama M, Numata A, Ishiyama Y, Takasaki H, Washimi K, Kawachi K, Yokose T, Nakamura N, Sakai R, Nakajima H.

Rinsho Ketsueki. 2017;58(7):749-754. doi: 10.11406/rinketsu.58.749. Japanese.

PMID:
28781269
32.

Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?

Ito H, Nakayama H, Murakami S, Yokose T, Katayama K, Miyata Y, Okada M.

Gen Thorac Cardiovasc Surg. 2017 Sep;65(9):512-518. doi: 10.1007/s11748-017-0790-0. Epub 2017 Jun 7.

PMID:
28593420
33.

Prognostic contribution of non-predominant solid and micropapillary components in lung adenocarcinomas.

Suzuki M, Yokose T, Nakayama H.

J Thorac Dis. 2017 Mar;9(3):504-506. doi: 10.21037/jtd.2017.03.15. No abstract available.

34.

Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.

Matsushima J, Yazawa T, Suzuki M, Takahashi Y, Ota S, Nakajima T, Yoshino I, Yokose T, Inoue T, Kawahara K, Nakatani Y.

Hum Pathol. 2017 Jun;64:179-185. doi: 10.1016/j.humpath.2017.04.006. Epub 2017 Apr 21.

PMID:
28438615
35.

Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.

Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M.

Breast Cancer. 2017 Nov;24(6):748-755. doi: 10.1007/s12282-017-0774-z. Epub 2017 Apr 19.

PMID:
28425014
36.

Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma.

Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Takita M, Mitsunaga S, Mizoguchi N, Nonaka T, Nakayama Y, Oridate N.

Head Neck Pathol. 2017 Dec;11(4):477-486. doi: 10.1007/s12105-017-0814-1. Epub 2017 Apr 3.

37.

HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.

Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K.

Sci Rep. 2017 Mar 31;7:45768. doi: 10.1038/srep45768.

38.

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.

Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Yamanaka A, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M.

BMC Cancer. 2017 Feb 27;17(1):160. doi: 10.1186/s12885-017-3154-3.

39.

Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.

Nagata M, Ito H, Matsuzaki T, Furumoto H, Isaka T, Nishii T, Yokose T, Nakayama H.

Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1164-1170. doi: 10.1093/ejcts/ezx004.

PMID:
28199511
40.

[A Case of Unresectable Advanced Rectal Cancer with a Pancreatic Tumor That Was Successfully Treated with FOLFIRINOX].

Yabe N, Murai S, Ozawa H, Yokose T, Oto I, Yoshikawa T, Kitasato K, Shimizu H, Kojima K, Hasegawa H, Kitagawa Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2468-2470. Japanese.

PMID:
28133357
41.

[A Case of Primary Splenic Inflammatory Myofibroblastic Tumor].

Atsumi Y, Murakawa M, Yamaoku K, Aoyama T, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Washimi K, Yokose T, Yamamoto N, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2268-2270. Japanese.

PMID:
28133291
42.

Duodenal Rare Neuroendocrine Tumor: Clinicopathological Characteristics of Patients with Gangliocytic Paraganglioma.

Okubo Y, Yokose T, Motohashi O, Miyagi Y, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Nemoto T, Shibuya K, Kameda Y.

Gastroenterol Res Pract. 2016;2016:5257312. doi: 10.1155/2016/5257312. Epub 2016 Dec 21. Review.

43.

Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.

Isaka T, Nakayama H, Yokose T, Ito H, Katayama K, Yamada K, Masuda M.

Ann Thorac Cardiovasc Surg. 2017 Feb 20;23(1):19-25. doi: 10.5761/atcs.oa.16-00164. Epub 2016 Dec 27.

44.

The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.

Okubo Y, Motohashi O, Nakayama N, Nishimura K, Kasajima R, Miyagi Y, Shiozawa M, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Kameda Y, Yokose T.

Diagn Pathol. 2016 Nov 8;11(1):128.

45.

Highly sensitive detection of invasive lung cancer cells by novel antibody against amino-terminal domain of laminin γ2 chain.

Miyazaki K, Oyanagi J, Sugino A, Sato H, Yokose T, Nakayama H, Miyagi Y.

Cancer Sci. 2016 Dec;107(12):1909-1918. doi: 10.1111/cas.13089. Epub 2016 Dec 12.

46.

Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.

Tsubokawa N, Mimae T, Miyata Y, Sasada S, Yoshiya T, Kushitani K, Takeshima Y, Murakami S, Yokose T, Ito H, Nakayama H, Okada M.

Jpn J Clin Oncol. 2016 Aug 27. [Epub ahead of print]

PMID:
27566971
47.

Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary Adenocarcinoma.

Isaka T, Nakayama H, Yokose T, Ito H, Miyagi Y, Matsuzaki T, Nagata M, Furumoto H, Nishii T, Katayama K, Yamada K, Masuda M.

Ann Thorac Surg. 2016 Dec;102(6):1821-1828. doi: 10.1016/j.athoracsur.2016.06.001. Epub 2016 Aug 20.

PMID:
27553497
48.

Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.

Baghdadi M, Wada H, Nakanishi S, Abe H, Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, Kaga K, Miyagi Y, Yokose T, Takano A, Daigo Y, Seino KI.

Cancer Res. 2016 Oct 15;76(20):6030-6042. Epub 2016 Aug 22.

49.

Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.

Shiraishi K, Okada Y, Takahashi A, Kamatani Y, Momozawa Y, Ashikawa K, Kunitoh H, Matsumoto S, Takano A, Shimizu K, Goto A, Tsuta K, Watanabe SI, Ohe Y, Watanabe Y, Goto Y, Nokihara H, Furuta K, Yoshida A, Goto K, Hishida T, Tsuboi M, Tsuchihara K, Miyagi Y, Nakayama H, Yokose T, Tanaka K, Nagashima T, Ohtaki Y, Maeda D, Imai K, Minamiya Y, Sakamoto H, Saito A, Shimada Y, Sunami K, Saito M, Inazawa J, Nakamura Y, Yoshida T, Yokota J, Matsuda F, Matsuo K, Daigo Y, Kubo M, Kohno T.

Nat Commun. 2016 Aug 9;7:12451. doi: 10.1038/ncomms12451.

50.

Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.

Nishii T, Yokose T, Miyagi Y, Daigo Y, Isaka T, Furumoto H, Ito H, Murakami S, Kondo T, Saito H, Oshita F, Yamada K, Matsukuma S, Nakayama H, Masuda M.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e204-e211. doi: 10.1111/ajco.12512. Epub 2016 Jun 28.

PMID:
27349355

Supplemental Content

Loading ...
Support Center